Likewise, the work of Sgrignoli et al. [178] showed that 6 months after recurrent local delivery of allogenic AD-MSCs into the dog conjunctival sac, exhibited a considerable reduction in the expression of KCS markers; IL-6, IL-1, TNF, and CD4. Here, CD4 is linked to Alzheimer disease.